Tessie Che – Chairperson & GM, Amaran Biotech, Taiwan
Tessie Che, chairperson & GM of Amaran Biotech shares the story of how she came to lead the company and set its course to become a leading specialty biopharma CMO…
The Development Fund of the Executive Yuan is in its 30th year since establishment in 1973. In its early years, the Fund invested in petrochemical and semiconductor industries that were vital to national development plans. In recent years, the focus of its investment has shifted to the biotechnology and digital content industries; in line with Taiwan’s economic transformation and strategic development directions.
The Fund’s investment scope currently embraces semiconductors, optoelectronics, communications, financial services, precision machinery, transportation infrastructure, and biotechnology. The primary goal of the Fund is to serve as a catalyst for Taiwan’s economic development and to accomplish a multiplier effect in the courses of its investment process.
Economic development is the aspiration of all people in Taiwan. It is our expectation that the Development Fund can serve as a driver for Taiwan’s economy. Not only would the Fund propel forward our industries on the international stage, it would enable us to accomplish new grounds of industrial and economic achievements.
Tessie Che, chairperson & GM of Amaran Biotech shares the story of how she came to lead the company and set its course to become a leading specialty biopharma CMO…
Ying-Yao Cheng, president of National Sun Yat-sen University, highlights the institution’s specialized expertise in marine sciences and goes on to elaborate on the important role of NSYSU in developing talent,…
Adimmune Corporation is the only influenza vaccine manufacturer with both EU GMP and US FDA certification in Asia, as well as the only PIC/S GMP manufacturer of human vaccines in…
Nick Lee, general manager of Ipsen Taiwan, Hong Kong, and Macau, shares his journey of building up the affiliate after having separated from their local partner two years ago. Lee…
Jenny Chao and Aries Chang of BiotechTS, introduce the company as a leading one-stop-service provider for laboratory testing and explain its current transition from the food and safety space to…
Sheron Lin, president of Daiichi Sankyo Taiwan, elaborates on the affiliate’s tactical positioning in the region and a leading market for clinical trials and new product launches. Lin goes on…
Polly Lin, CEO of Guzip Biomarkers, discusses Guzip’s work in epigenetics and the role of DNA methylation in treating endometrial cancer. She highlights the benefits of MPap for women’s health…
Steve Profit, general manager of Novo Nordisk Taiwan, shares a newcomers’ perspective as a recent transplant to the market from the company’s global office in Denmark. Profit goes on to…
Dr Fuh-Sheng Shieu, president of National Chung Hsing University, elaborates on his ambitions to further NCHU’s positioning as one of Taiwan’s most impactful research universities. He goes on to highlight…
EPED is a professional medical equipment company and a leader in navigation system technologies based in Taiwan. Here, Founder & President Douglas Huang discusses EPED’s medical, dental and educational training…
Medimaging Integrated Solution Inc (MiiS) originated from the incubation center at the National Chiao Tung University (NCTU), Taiwan. MiiS started its business primarily based on the foundation of innovation, and…
Francis Hong, chairman of Taiwan Medical and Biotech Industry Association (TMBIA), takes a moment during the 2019 Medical Taiwan and Taiwan Medical Components & Manufacturing Expo (MCMEX) in Taipei to share…
See our Cookie Privacy Policy Here
